Surgical journey for participants (Pts) in the MATTERHORN trial: A global, randomized, phase 3 study of durvalumab (D) plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (Flot) in resectable gastric/gastroesophageal junction (G/gej) adenocarcinoma
Molena, D., Hyung, W. J., Wainberg, Z. A., Liberman, M., Folprecht, G., Diaz, I. A., Yoshikawa, T., Al-Batran, S.-E., Van … Read More
